Miguel-Hidalgo Jose Javier, Dubey Priti, Shao Qingmei, Stockmeier Craig, Rajkowska Grazyna
Department of Psychiatry, University of Mississippi Medical Center, 2500 North State Street, P.O. Box 127, Jackson, MS 39216, USA.
Schizophr Res. 2005 Jul 15;76(2-3):159-71. doi: 10.1016/j.schres.2005.02.015.
Morphometric changes in the general population of Nissl-stained neurons in area 9 of the dorsolateral prefrontal cortex have been reported in major depressive disorder (MDD) and schizophrenia. These alterations include lamina-specific reductions in the packing density of neuronal somata in MDD, increases or reductions in the density of neuronal somata in schizophrenia, and reductions in average size of neuronal somata in both MDD and schizophrenia. These changes are prominent in deep layer III, where pyramidal excitatory neurons establishing cortico-cortical association connections are localized. To test whether deep layer III pyramidal neurons are differentially affected in MDD or schizophrenia, an antibody was used that labels both phosphorylated and non-phosphorylated forms of the 200 kD neurofilament protein (NF200) in pyramidal cells of layer III in area 9. The packing density and somal size of NF200-immunoreactive (IR) pyramidal neurons were measured in area 9 in 13 subjects with nonpsychotic MDD, 11 subjects with schizophrenia and 13 psychiatrically normal controls. Analysis of covariance did not reveal a difference in packing density among groups. However, the mean size of NF200-IR somata was significantly larger in subjects with schizophrenia than in controls. These results indicate that this neuronal subpopulation does not contribute to the smaller average size of neuronal somata in layer III of prefrontal cortical area 9 in schizophrenia or MDD. In addition, the enlarged somal size in schizophrenia as compared to controls suggests that NF200 neurons may contribute differentially to unique cognitive disturbances present in schizophrenia and not in MDD subjects.
在重度抑郁症(MDD)和精神分裂症患者中,已报道背外侧前额叶皮质9区经尼氏染色的神经元总体形态计量学变化。这些改变包括:MDD患者神经元胞体堆积密度在特定层减少;精神分裂症患者神经元胞体密度增加或减少;MDD和精神分裂症患者神经元胞体平均大小均减小。这些变化在深层III中很明显,建立皮质-皮质联合连接的锥体兴奋性神经元就位于该层。为了测试深层III锥体神经元在MDD或精神分裂症中是否受到不同影响,使用了一种抗体,该抗体可标记9区III层锥体细胞中200 kD神经丝蛋白(NF200)的磷酸化和非磷酸化形式。在13名非精神病性MDD患者、11名精神分裂症患者和13名精神正常的对照者中,测量了9区NF200免疫反应性(IR)锥体神经元的堆积密度和胞体大小。协方差分析未显示各组之间在堆积密度上存在差异。然而,精神分裂症患者中NF200-IR胞体的平均大小显著大于对照组。这些结果表明,在精神分裂症或MDD患者中,这一神经元亚群对前额叶皮质9区III层神经元胞体平均大小减小并无影响。此外,与对照组相比,精神分裂症患者胞体增大表明,NF200神经元可能对精神分裂症患者而非MDD患者中存在的独特认知障碍有不同的影响。